PHARMA ONLINE WHITE PAPERS

  • Advancing Drug Development With Optimized LC-MS/MS Bioanalysis
    5/7/2025

    Explore the critical role of sample preparation optimization and the application of liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) in bioanalytical method development.

  • Avoiding The Pitfalls Of PQR
    10/9/2024

    Explore the fundamentals of Product Quality Reviews (PQRs), common challenges manufacturers face, strategies for streamlining PQRs, and solutions that aim to unlock the potential of a "real-time PQR."

  • Best Practices In Commissioning And Qualification
    7/5/2024

    An integrated approach to C&Q ensures coordination and synchronization between commissioning and qualification activities, enhancing both regulatory compliance and product safety.

  • Engineering The Next Wave Of CHO Performance
    3/24/2026

    By combining improved productivity with speed and reliability, S-CHOice® 2G helps biopharmaceutical companies optimize their manufacturing strategies, reduce overall costs, and respond more effectively to market demands.

  • SMB Technology: Optimizing API Purification
    6/13/2025

    Explore how Simulated Moving Bed (SMB) technology can enhance API production while overcoming common misconceptions about chromatographic purification.

Katie-Anderson-Chief-Editor

INDUSTRY NEWS

  • Høeg In, Pazdur Out At The FDA

    What an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.

  • 9 Drugs Granted Fast Track By FDA's Voucher Program

    With targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.

  • Leaders In The Excipient Market: Region And Type

    Though North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.

  • Pfizer Strengthens Obesity Foothold With Metsera Acquisition

    After discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.

  • FDA Cracks Down On GLP-1 Imports

    GLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.

PHARMACEUTICAL ONLINE CONTENT COLLECTIONS

MilliporeSigma Pharm Online Ebook

 

Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.

More Content Collections

SUPPLIER NEWS